Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sea Limited
SE
|
+$1.96B |
| 2 |
AbbVie
ABBV
|
+$1.42B |
| 3 |
D.R. Horton
DHI
|
+$783M |
| 4 |
Amazon
AMZN
|
+$603M |
| 5 |
Eli Lilly
LLY
|
+$586M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.18B |
| 2 |
EOG Resources
EOG
|
+$999M |
| 3 |
JPMorgan Chase
JPM
|
+$874M |
| 4 |
Comcast
CMCSA
|
+$746M |
| 5 |
TC Energy
TRP
|
+$626M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Industrials | 10.84% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Coursera
COUR
$1.49B
| $14M | ﹤0.01% |
1,299,700
-3,602,742
| -73% | -$47.7M |
|
377
Haleon
HLN
$43.1B
| $13.3M | ﹤0.01% |
+2,188,391
| New | +$14.2M |
|
378
AppFolio
APPF
$6.92B
| $12.8M | ﹤0.01% |
121,943
-145,683
| -54% | -$14.9M |
|
379
Vaxcyte
PCVX
$8.93B
| $12.7M | ﹤0.01% |
+514,856
| New | +$13.1M |
|
380
Itaú Unibanco
ITUB
$81.1B
| $12.2M | ﹤0.01% |
2,684,305
| – | – |
|
381
Strategy Inc
MSTR
$37.8B
| $11.9M | ﹤0.01% |
+561,280
| New | +$14.1M |
|
382
Freshpet
FRPT
$3.48B
| $11.9M | ﹤0.01% |
237,764
-1,639,851
| -87% | -$77.3M |
|
383
Trupanion
TRUP
$1.33B
| $11.9M | ﹤0.01% |
200,000
-100,000
| -33% | -$6.72M |
|
384
Alcoa
AA
$13.3B
| $11.8M | ﹤0.01% |
350,000
| – | – |
|
|
CVE.WS
385
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $11.3M | ﹤0.01% |
1,066,345
| – | – |
|
386
ICF International
ICFI
$1.57B
| $9.99M | ﹤0.01% |
+91,666
| New | +$9.22M |
|
387
Cushman & Wakefield Ltd
CWK
$3.26B
| $9.87M | ﹤0.01% |
862,000
-1,000,000
| -54% | -$15.1M |
|
388
StoneCo
STNE
$2.45B
| $9.76M | ﹤0.01% |
1,024,049
-7,104,920
| -87% | -$68M |
|
389
Materion
MTRN
$5.98B
| $9.72M | ﹤0.01% |
+121,538
| New | +$10M |
|
390
Twilio
TWLO
$38.6B
| $9.62M | ﹤0.01% |
+139,125
| New | +$11.1M |
|
|
HTO
391
H2O America
HTO
$2.65B
| $9.33M | ﹤0.01% |
+162,000
| New | +$10.4M |
|
392
ON Semiconductor
ON
$32.4B
| $9.06M | ﹤0.01% |
145,439
-581,343
| -80% | -$37.4M |
|
|
CHX
393
DELISTED
ChampionX
CHX
| $9.05M | ﹤0.01% |
+462,625
| New | +$9.54M |
|
394
LivePerson
LPSN
$34.8M
| $8.01M | ﹤0.01% |
56,674
+15,000
| +36% | +$2.87M |
|
395
Steven Madden
SHOO
$3.45B
| $7.39M | ﹤0.01% |
+277,000
| New | +$8.72M |
|
396
LXP Industrial Trust
LXP
$3.58B
| $7.38M | ﹤0.01% |
+161,085
| New | +$8.38M |
|
|
NXGN
397
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $7.19M | ﹤0.01% |
+406,300
| New | +$7.05M |
|
|
UNVR
398
DELISTED
Univar Solutions Inc.
UNVR
| $7.18M | ﹤0.01% |
+315,595
| New | +$7.93M |
|
399
Intel
INTC
$530B
| $7.13M | ﹤0.01% |
276,605
-1,230,000
| -82% | -$41.9M |
|
|
THS
400
DELISTED
Treehouse Foods
THS
| $6.46M | ﹤0.01% |
+152,200
| New | +$6.83M |
|
Similar funds
Capital Research Global Investors's Q3 2022 Portfolio in Review
As of Q3 2022, Capital Research Global Investors held 452 positions worth $304B, down 5.2% from $321B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q3 2022 filing shows 29 new, 189 increased, 162 reduced and 23 closed positions. Its largest new stake was Centene: 2,829,733 shares worth $220M. The largest sale was Canadian Natural Resources, an estimated $1.18B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Capital Research Global Investors's largest Q3 2022 buy was Centene: 2,829,733 shares worth $220M.
- Capital Research Global Investors added most to Sea Limited in Q3 2022, an estimated $1.96B increase.
- Capital Research Global Investors's biggest Q3 2022 reduction was Canadian Natural Resources, cutting an estimated $1.18B.
- Capital Research Global Investors fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q3 2022, selling an estimated $210M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $304B portfolio in Q3 2022.
- Capital Research Global Investors opened 29 new positions and closed 23 in Q3 2022.
- Capital Research Global Investors's portfolio value fell 5.2% quarter-over-quarter to $304B.
Based on Capital Research Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.